ERF628 - RADIOPHARMACEUTICALS
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
RADIOPHARMACEUTICALS | ERF628 | Any Semester/Year | 2 | 0 | 2 | 7 |
Prequisites | None | |||||
Course language | English | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion | |||||
Instructor (s) | Prof.Dr. Suna Erdoğan, Prof. Dr. A. Yekta Özer, Assist.Prof.Dr. Mine Silindir Günay | |||||
Course objective | The course aim is to introduce the student radionuclide production, the radiopharmaceuticals in pharmacopoeia and to teach their usage in clinics. | |||||
Learning outcomes |
| |||||
Course Content | - Terminology - Principles of radiopharmaceuticals - Officinal and new radiopharmaceuticals; quality control, industrial production, design of new radiopharmaceuticals - Tc-99m radiopharmaceuticals - Radioiodinated radiopharmaceuticals - PET radiopharmaceuticals - Radiopharmaceuticals labeled with other radionuclides - Parameters effecting the usage of radiopharmaceuticals | |||||
References | 1- A Theobald, Radiopharmaceuticals: Using Radioactive Compounds in Pharmaceutics and Medicine, Taylor & Francis, 1989. 2- GA Andrews, RM Kniseley, HN Wagner, Radioactive Pharmaceuticals, 1966. 3- Gopal B. Saha, Fundamentals of Nuclear Pharmacy, New York, Springer, 2004. 4- IAEA TEC DOC , Production of 99mTc-Radiopharmaceuticals for Brain, Heart, Kidney Imaging, 1995. 5- IAEA TEC DOC 649, Preparation Kits for 99mTc Radiopharmaceuticals, 1992. |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | Introduction and terminology |
Week 2 | Principles in radiopharmaceuticals |
Week 3 | Officinal and new radiopharmaceuticals; quality control, industrial production |
Week 4 | Officinal and new radiopharmaceuticals; Tc-99m Radiopharmaceuticals |
Week 5 | Officinal and new radiopharmaceuticals; Tc-99m Radiopharmaceuticals (cont) |
Week 6 | Midterm exam |
Week 7 | Officinal and new radiopharmaceuticals; radioiodinated radiopharmaceuticals |
Week 8 | Officinal and new radiopharmaceuticals; radioiodinated radiopharmaceuticals(cont |
Week 9 | Officinal and new radiopharmaceuticals; PET radiopharmaceuticals |
Week 10 | Officinal and new radiopharmaceuticals; radiopharmaceuticals labeled with other radionuclides |
Week 11 | Officinal and new radiopharmaceuticals; radiopharmaceuticals labeled with other radionuclides (cont) |
Week 12 | Design of new radiopharmaceuticals |
Week 13 | Parameters effecting the usage of radiopharmaceuticals (cont) |
Week 14 | Parameters effecting the usage of radiopharmaceuticals (cont) |
Week 15 | Arrangements for final exam |
Week 16 | Final exam |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 0 | 0 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 0 | 0 |
Presentation | 0 | 0 |
Project | 0 | 0 |
Seminar | 0 | 0 |
Midterms | 1 | 50 |
Final exam | 1 | 50 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 1 | 50 |
Percentage of final exam contributing grade succes | 1 | 50 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 2 | 28 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 2 | 28 |
Presentation / Seminar Preparation | 0 | 0 | 0 |
Project | 0 | 0 | 0 |
Homework assignment | 0 | 0 | 0 |
Midterms (Study duration) | 1 | 64 | 64 |
Final Exam (Study duration) | 1 | 90 | 90 |
Total Workload | 30 | 158 | 210 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. Searches current information in his field. Knows how to conduct scientific research and access information sources, and evaluates and uses this information. | |||||
2. Designs, carries out and evaluates scientific studies using theoretical and practical knowledge at the level of expertise acquired in that field. | X | ||||
3. Performs statistical analysis and interpretation of data obtained from studies. | |||||
4. Presents the results obtained from scientific studies in scientific meetings, prepare the reports of results and publishes the results of studies in national and/or international journal. | |||||
5. Has the theoretical knowledge and appropriate skills on formulation, manufacturing, stability, quality assurance, regulatory affairs, and other regulations and distributions of radiopharmaceuticals. | X | ||||
6. Has the knowledge on effect of radiation on pharmaceutics, cosmetics and their raw materilas, drug delivery systems and medical devices and know how to control and/or prevent the possible changes occured by gamma irradiation. | |||||
7. Knows the biological effect of ionized radiation. Follow the rules required for radiation protection to protect the radiation worker, public and environment. | |||||
8. Applies the principles of GMP and GRP in whole process of life cycle of radiopharmacuticals. | |||||
9. Applies principles of professional development and lifelong learning, communication and social skills on professional practices. |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest